Risk Evaluation and Mitigation Strategy (REMS) Archives

Home Tags Risk Evaluation and Mitigation Strategy (REMS)

From FDA Landmark to Market Exit: The Complex Journey of Palforzia

Dave Bloom - 2026/01/28 0

How the First FDA-Approved Therapy for Peanut Allergy is Helping Families

Aimmune - 2021/03/17 0

Aimmune Warns Coronavirus Will Slow Marketing of Palforzia Treatment for Peanut...

Dave Bloom - 2020/03/17 0

Aimmune Provides FDA Mandated Program for Patients Considering Treatment of Peanut...

Dave Bloom - 2020/02/23 0

AAAAI Addresses What Patients and Their Families Need to Know About...

News Wire ~ 3rd Party Press Release - 2019/09/17 0

Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Tag: Risk Evaluation and Mitigation Strategy (REMS)

From FDA Landmark to Market Exit: The Complex Journey of Palforzia

How the First FDA-Approved Therapy for Peanut Allergy is Helping Families

Aimmune Warns Coronavirus Will Slow Marketing of Palforzia Treatment for Peanut...

Aimmune Provides FDA Mandated Program for Patients Considering Treatment of Peanut...

AAAAI Addresses What Patients and Their Families Need to Know About...

Follow Us